Panacea Biotec: Amongst the top 50 innovators in India; Buy for an upside of 12% | Rudra Shares |

Robust product pipeline of promising niche products to fuel long term future growth, Strong Product Portfolio with significant brand market share in respective therapeutic segment, PANACEA is amongst the top 50 innovators in India with strong foundation of over two decades.

USFDA NOD- Prasugrel Tablets

First-to-file abbreviated new drug application (ANDA) of Prasugrel 5 mg and 10 mg tablets- an important milestone to achieve growth in US business, has been approved from the US health regulator (as on 24th oct,17) , used for preventing blood clots in people with acute coronary syndrome, in the American market. The company is also entitled for 180 days of shared market exclusivity for the Prasugrel HCL tablets. The annual sale of Prasugrel prior to entry of generics in the market was around USD 600 million in the US market. The tablets are indicated for reduction of thrombotic cardiovascular events in people with acute coronary syndrome.
   Click here to read the full report

About Rudra Shares and Stock Brokers

RUDRA is one of the growing & dynamic brokerage houses with a strong presence in the Retail and HNI broking segment. With over 25 years of experience and lead by a team with outstanding managerial acumen, RUDRA is a professionally managed company supported by over 100 professionals, including Chartered Accountants, MBAs and other senior executives. RUDRA can thereby cater to its clients’ short-term as well as long-term financial needs through a comprehensive bouquet of investment services. RUDRA offers a diverse range of financial services, including institutional and retail brokerage of Equity, Currency, Commodities, Derivatives, Online Trading, Depository Services, Fixed Deposits, IPOs and Mutual Funds Distribution, and Wealth Advisory & Research. RUDRA is looking to become one of the biggest broking houses. RUDRA Securities Limited, is a member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited, MCX Stock Exchange, and Depository Participant of Central Depository Services (I) Limited. RUDRA can be approached online at


For more information please write in to [email protected]

Disclaimer: The author has taken due care and caution to compile and analyse the data. The opinions expressed above are only the views of the author, and not a recommendation to buy or sell. Neither the author nor accept any liability whatsoever arising from the use of any of the above contents.